Teachers Advisors’s Voyager Therapeutics VYGR Stock Holding History

Teachers Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.67M	Buy	139,215 +89,750	+181%	+$1.17M	﹤0.01%	1799
2018 Q4	$465K	Hold	49,465	–	–	﹤0.01%	2543
2018 Q3	$936K	Buy	49,465 +3,621	+8%	+$69.5K	﹤0.01%	2346
2018 Q2	$896K	Buy	45,844 +4,972	+12%	+$98.3K	﹤0.01%	2382
2018 Q1	$768K	Buy	40,872 +8,058	+25%	+$174K	﹤0.01%	2336
2017 Q4	$545K	Buy	32,814 +9,699	+42%	+$166K	﹤0.01%	2528
2017 Q3	$476K	Sell	23,115 -2,570	-10%	-$29K	﹤0.01%	2604
2017 Q2	$230K	Buy	25,685 +5,081	+25%	+$51.1K	﹤0.01%	2974
2017 Q1	$273K	Hold	20,604	–	–	﹤0.01%	2787
2016 Q4	$262K	Buy	20,604 +1,847	+10%	+$23.7K	﹤0.01%	2827
2016 Q3	$225K	Hold	18,757	–	–	﹤0.01%	2841
2016 Q2	$206K	Buy	18,757 +12,895	+220%	+$158K	﹤0.01%	2886
2016 Q1	$51K	Hold	5,862	–	–	﹤0.01%	3006
2015 Q4	$128K	Buy	+5,862	New	+$135K	﹤0.01%	2984

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

Teachers Advisors's VYGR Position: Q1 2019 in Review

Teachers Advisors increased its Voyager Therapeutics (VYGR) stake by 181% in Q1 2019, buying an estimated $1.17M and bringing the position to 139,215 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Teachers Advisors first reported a position in VYGR in Q4 2015 and has held it in 14 quarters since. 111 funds tracked by Wall St. Rank hold VYGR as of Q1 2019.

Teachers Advisors held 139,215 shares of Voyager Therapeutics worth $2.67M as of Q1 2019.
Teachers Advisors bought 89,750 Voyager Therapeutics shares in Q1 2019, an estimated $1.17M.
Voyager Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1799 holding.
Teachers Advisors first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 14 quarters since.
111 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.